Fundrise Fund Falls Mania: VCX Slumps 45% as IPO Mania Fades
The Fundrise VCX fund, once a magnet for IPO-obsessed investors, dropped 45% from its peak as market enthusiasm for p...
Learn the basics of currency risk in international funds and how it can affect diversification and overall performance.
26,930 articlesThe Fundrise VCX fund, once a magnet for IPO-obsessed investors, dropped 45% from its peak as market enthusiasm for p...
Inflation talk isn’t just for economists. Ken Griffin’s recent remarks signal a forceful shift in market expectations...
Choosing the right pharmaceutical ETF can shape your portfolio’s risk and income. This guide pits IHE against PJP, br...
A little-known rule could turn leftover 529 funds into a tax-free retirement windfall. If a 62-year-old with $35,000 ...
Three energy-focused ETFs are delivering roughly 7% yields in 2026 while avoiding K-1 tax forms. They promise simpler...
The U.S. Department of Housing and Urban Development has halted new funding to VIHFA while investigators probe allega...
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
As America marks its 250th anniversary, a landmark IPO led by Elon Musk tests market appetite and rekindles questions...
Investors want to know how far the S&P 500 can rise. Wall Street analysts see potential, but also risk. This guide ex...
History isn’t a crystal ball, but it’s a powerful guide. Learn how the long arc of markets offers fantastic news for ...
Global markets pulled back after Iran strikes sparked a heated political response. Investors weigh consequences for s...
A veteran figure in AI, nicknamed the 'godfather ai,' argues big tech prioritizes short-term profits over the endgame...